Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Friday, November 6, 2020
FDA Takes Efforts to Protect Patients from Potentially Harmful Compounded Drugs Through Finalizing Insanitary Conditions Guidance The following is attributed to Patrizia Cavazzoni, M.D., Acting Director, FDA Center for Drug Evaluation and Research.
|
Thursday, November 5, 2020
Tuesday, November 3, 2020
11/03/2020 | 10/09/2020 | Surgery Pharmacy Services Inc | Division of Pharmaceutical Quality Operations II | Compounding Pharmacy/Adulterated Drug Products |
11/03/2020 | 10/15/2020 | Cosmax USA, Inc. | Division of Pharmaceutical Quality Operations II | CGMP/Finished Pharmaceuticals/Adulterated |
11/03/2020 | 10/16/2020 | Immusist, LLC | Division of Human and Animal Food Operations West VI | New Drug/Misbranded |
11/03/2020 | 10/22/2020 | Handylee USA Corp. | Division of Northeast Imports | Foreign Supplier Verification Program (FSVP) | ||
11/03/2020 | 10/23/2020 | 4E Global, S.A.P.I. de C.V. | Center for Drug Evaluation and Research | CDER | CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated | ||
11/03/2020 | 10/23/2020 | Grupo Insoma, S.A.P.I de CV | Center for Drug Evaluation and Research | CDER | CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated | ||
11/03/2020 | 10/27/2020 | Real Clean Distribuciones SA de CV | Center for Drug Evaluation and Research | CDER | CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated | ||
11/03/2020 | 10/29/2020 | Asiaticon, SA de CV | Center for Drug Evaluation and Research | CDER | CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated |